Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Inflammation Research"
DOI: 10.2147/jir.s348786
Abstract: Background Toll-like receptor 3 (TLR3) not only plays a crucial role in innate immune and inflammation but also in anti-cancer immunity. Nevertheless, the clinicopathological outcome of TLR3 in ESCC is still ambiguous. Methods Immunohistochemistry was…
read more here.
Keywords:
expression;
tlr3 expression;
prognosis;
microenvironment ... See more keywords